Clinical trial software market seen reaching $2.53 billion by 2030
The Business Research Company says the clinical trial software market is growing quickly as drug research becomes more complex and data-heavy. The market is projected to rise from $1.32 billion in 2025 to $2.53 billion by 2030, with North America leading and Europe expected to grow fastest.
Why it matters: - Clinical trial software is becoming more central to drug development as research teams manage larger data sets, tighter oversight and more distributed trials. - The market’s forecast growth signals rising demand for tools that improve trial speed, transparency and compliance across global research programs.
What happened: - The Business Research Company released its Clinical Trial Software Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035 on Nov. 19, 2026. - The report says the market will grow from $1.32 billion in 2025 to $1.51 billion in 2026. - The report projects the market will reach $2.53 billion by 2030. - The report estimates a 14.1% CAGR for the historical period and 13.8% CAGR through 2030. - A free sample of the report is available here. - The full report is available here.
The details: - Clinical trial software covers applications used to plan, run and oversee clinical trials. - The software supports data management, patient recruitment, regulatory compliance and real-time monitoring of trial progress. - The report links market growth to digitization of trial operations, rising trial-data volumes, demand for real-time transparency, global expansion of clinical research and wider access to advanced software platforms. - Future growth is expected to come from virtual and decentralized trials, higher investment in SaaS-based solutions, AI integration, remote patient monitoring and stricter regulatory focus on data integrity. - The report highlights cloud-based software, AI-driven analytics, decentralized trial platforms, integrated electronic data capture and clinical trial management systems, and stronger data security and compliance as key trends. - The report also says the 2026 edition adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.
Between the lines: - The report’s emphasis on SaaS, cloud tools and AI suggests the market is shifting from basic trial administration to more automated and connected workflows. - The focus on security, compliance and data integrity reflects the pressure regulators are placing on digital trial systems as adoption expands. - R&D spending remains a demand driver for clinical trial software, with UK government net R&D spending rising to £17.4 billion ($22.1 billion) in 2023 from £16.1 billion ($20.45 billion) in 2022, according to the Office for National Statistics.
What's next: - The report expects wider adoption of virtual and decentralized clinical trials to keep pushing software demand higher through 2030. - North America held the largest market share in 2025, while Europe is projected to be the fastest-growing region during the forecast period. - Other regions covered in the analysis include Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East and Africa. - The Business Research Company lists Saumya Sahay as a contact for more information, with the company’s main site available here.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
United Kingdom Political Times
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.